Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2023 | Clinical efficacy and safety of CT-P10 in patients with DLBCL

Mark Bishton, MBChB, MRCP, FRCPath, PhD, Nottingham University Hospitals NHS Foundation Trust, Nottingham, UK, shares some insights into a study evaluating the real-world safety and efficacy of CT-P10 in patients with diffuse large B-cell lymphoma (DLBCL). This interview took place at the 63rd Annual Scientific Meeting of the British Society for Haematology (BSH) 2023, held in Birmingham, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Roche – conference travel, ad board
Takeda – educational meeting
Lilly – ad board
Celltrion – educational meetings
Incyte – ad board